Skip to content

Early Onset Preeclampsia and Nectin-4

Serum Nectin-4 Levels in Patients With Early Onset Preeclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05098691
Enrollment
84
Registered
2021-10-28
Start date
2020-05-01
Completion date
2020-12-30
Last updated
2021-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Onset Preeclampsia, Immunologic Diseases in Pregnancy, Oxidative Stress, Pre-Eclampsia

Keywords

early onset preeclampsia, nectin-4, advers pregnancy outcome, hypertansion

Brief summary

Early-onset Preeclampsia (PE) is a pregnancy disorder which may present with adverse pregnancy outcomes. Nectin-4 is an adhesion molecule mainly expressed in placenta. This study aimed to evaluate the relationship between early onset Preeclampsia and serum Nectin 4 levels.

Detailed description

Preeclampsia is assumed as a two-stage disorder arising from defective trophoblast invasion and failure of spiral artery remodeling as the main step responsible for the pathogenesis. PE is classified according to the disease onset time as early-onset PE before 34 weeks and late-onset PE after 34 weeks. Late-onset PE is more commonly seen and accepted as a mild maternal reaction to pregnancy. In early-onset PE, unlike the late-onset, due to the improper placental invasion, the diffuse placental ischemia and the resulting oxidative stress begin at early gestation. Thus, the early-onset PE may result in severe disease leading to perinatal and maternal morbidity and mortality. The nectins are calcium-independent immunoglobulin-like celladhesion molecules and have a pivotal role at cellular junctions, as well as physiological regulations(8). Placenta expressesfor types of nectins; nectin-1, nectin-2, nectin-3, and nectin-4. They are localized at tight junctions and gap junctions of syncitiotrophoblasts(9). Nectin-4 is a relatively novel member of nectin family which has been detected only in placenta and airway epithelium in healthy subjects. Despite, there has been no study published yet to reveal the soluble nectin-4 levels in preeclampsia as well as in early onset disease. In this study, we aimed to investigate the serum nectin-4 levels in early-onset preeclampsia in comparison of the healthy pregnancies.

Interventions

DIAGNOSTIC_TESTserum marker levels

two groups comparisons

Sponsors

Hatice Akkaya
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* spontaneous, * singleton pregnancies * above the 24 weeks of gestations * positive fetal cardiac activity

Exclusion criteria

* multiple gestations, * chronic hypertension * hypothyroidism * known malignancy,- diabetes mellitus, * presence of fetal or maternal infection, * clinical signs of chorioamnionitis (maternal fever, vaginal discharge, fetal tachycardia), * hepatic or renal failure * Placenta previa or pregnancies accompanied congenital fetal abnormalities or aneuploidies

Design outcomes

Primary

MeasureTime frameDescription
serum nectin-4 levels1 hourng/ml

Secondary

MeasureTime frameDescription
BMI (body mass index)5 minutekg/m2
Tansion Arterial5 minutemm Hg

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026